Literature DB >> 15158329

Linkage disequilibrium between HLA class II region and autoimmune hepatitis in pediatric patients.

Idriss Djilali-Saiah1, Reginald Renous, Sophie Caillat-Zucman, Dominique Debray, Fernando Alvarez.   

Abstract

BACKGROUND/AIMS: Susceptibility HLA class II alleles associated with autoimmune hepatitis (AIH) were only described in case-control studies.
METHODS: The transmission/disequilibrium test was used in 50 simplex families with AIH, to determine if affected offspring received the disease-associated allele more frequently than its alternate. HLA-DRB1 and DQB1 allele genotyping and autoimmune regulator (AIRE) polymorphisms located in exons 6, 8 and 10 were investigated by PCR-based methods.
RESULTS: HLA-DRB1*03 allele was significantly transmitted from heterozygous parent to affected offspring (81.5%) with type 1 AIH compared to random expected frequency (50.0%; P=0.004) or to unaffected offspring (42.8%; P=0.03). HLA-DRB1*1301 allele showed an excess transmission to affected children (100%) than expected frequency (P<0.0001) or unaffected offspring (P=0.001). The transmission of DQB1*201 or DQB1*0603 alleles showed significant deviation in patients compared to random frequencies: (84.8%; P<0.0001 for DQB1*0201 or 100%; P<0.0001 for DQB1*0603). HLA-DQB1*0201 showed a strong association with type 2 AIH in children (100.0%, P=0.0005).
CONCLUSIONS: HLA-DRB1 gene is the major genetic determinant in HLA class II region for children with type 1 AIH. Type 2 AIH is associated with the HLA-DQB1gene. Finally, AIRE gene abnormality does not contribute to the development of isolated AIH.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15158329     DOI: 10.1016/j.jhep.2004.02.023

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  15 in total

Review 1.  Autoantibodies as prognostic markers in autoimmune liver disease.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2010-05-13       Impact factor: 3.199

Review 2.  Global Disparities and Their Implications in the Occurrence and Outcome of Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2017-07-14       Impact factor: 3.199

Review 3.  Pathogens and autoimmune hepatitis.

Authors:  U Christen; E Hintermann
Journal:  Clin Exp Immunol       Date:  2018-10-07       Impact factor: 4.330

4.  A novel "humanized mouse" model for autoimmune hepatitis and the association of gut microbiota with liver inflammation.

Authors:  Muhammed Yuksel; Yipeng Wang; Ningwen Tai; Jian Peng; Junhua Guo; Kathie Beland; Pascal Lapierre; Chella David; Fernando Alvarez; Isabelle Colle; Huiping Yan; Giorgina Mieli-Vergani; Diego Vergani; Yun Ma; Li Wen
Journal:  Hepatology       Date:  2015-08-25       Impact factor: 17.425

Review 5.  Transitioning from Idiopathic to Explainable Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2015-05-22       Impact factor: 3.199

6.  The early onset of type 1 autoimmune hepatitis has a strong genetic influence: role of HLA and KIR genes.

Authors:  A Podhorzer; N Paladino; M L Cuarterolo; H A Fainboim; S Paz; G Theiler; M Capucchio; S I López; A Machicote; S Montal; G Podesta; L Fainboim
Journal:  Genes Immun       Date:  2016-02-18       Impact factor: 2.676

7.  Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management.

Authors:  Ye H Oo; Stefan G Hubscher; David H Adams
Journal:  Hepatol Int       Date:  2010-05-19       Impact factor: 6.047

8.  Treatment of Autoimmune Hepatitis: Current and Future Therapies.

Authors:  Fernando Alvarez
Journal:  Curr Treat Options Gastroenterol       Date:  2004-10

Review 9.  Influence of genes, sex, age and environment on the onset of autoimmune hepatitis.

Authors:  Kathie Béland; Pascal Lapierre; Fernando Alvarez
Journal:  World J Gastroenterol       Date:  2009-03-07       Impact factor: 5.742

Review 10.  Clinical features and management of autoimmune hepatitis.

Authors:  Edward-L Krawitt
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.